CCSV - Post Market Clinical Follow-up Study
Chest Compression Synchronized Ventilation (CCSV) - an Exploratory Post Market Clinical Follow-up Study
1 other identifier
observational
98
1 country
1
Brief Summary
The main goal of this observational study is the evaluation of Chest Compression Synchronized Ventilation (CCSV) regarding oxygenation in terms of PaO2 assessed by routine blood gas analysis, hemodynamic effects, 30-day outcome and safety in comparison to Intermittent Positive Pressure Ventilation (IPPV) as data in humans is sparse especially in direct comparison to other ventilation modes. Cardiac arrest patients in Vienna, Austria will be preclinically randomized (IPPV and CCSV) and ventilated accordingly during CPR. Differences in oxygenation, decarboxylation, systemic perfusion and cerebral oxygenation, the patient's 30-day outcome as well as ventilator-associated adverse events (e.g., pneumothorax) will be recorded and analyzed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 28, 2024
CompletedStudy Start
First participant enrolled
June 1, 2024
CompletedFirst Posted
Study publicly available on registry
February 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
ExpectedFebruary 20, 2025
May 1, 2024
2 years
May 28, 2024
February 14, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Oxygenation
Difference in PaO2 between IPPV and CCSV group
24 months
Secondary Outcomes (4)
Decarboxylation
24 months
systemic perfusion
24 months
patient outcome
27 months
ventilator-associated adverse events
27 months
Study Arms (2)
IPPV
Cardiac arrest patients ventilated with IPPV
CCSV
Cardiac arrest patients ventilated with CCSV
Eligibility Criteria
Adult out-of-hospital cardiac arrest patients in Vienna
You may qualify if:
- OHCA
- Correct endotracheal intubation (seen by capnography)
- The patient is being treated by the Vienna Emergency Medical Services within the scope of emergency ventilation.
- MEDUMAT Standard from Weinmann Emergency is used.
- Mechanical ventilation is performed according to the specified indications.
You may not qualify if:
- Patients eligible for eCPR (as defined by the standard operating procedure of the Emergency Medical Service Vienna)
- Patients recovering (reaching sustained ROSC) before starting mechanical ventilation or in the first three minutes of it
- Traumatic cardiac arrest
- Suspected or known pregnancy
- Clinically suspected (tension-)pneumothorax
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medical University of Viennalead
- WEINMANN Emergency, Medical Technology GmbH & Co. KGcollaborator
- Berufsrettung Wiencollaborator
Study Sites (1)
Medical University of Vienna
Vienna, Austria, 1090, Austria
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sebastian Schnaubelt, MD, PhD
Department of Emergency Medicine, Medical University of Vienna
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Adjunct Professor
Study Record Dates
First Submitted
May 28, 2024
First Posted
February 20, 2025
Study Start
June 1, 2024
Primary Completion
June 1, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
February 20, 2025
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share